Sort
15,842 grants matching “pancreatic cancer”
Molecular Determinants of Vascularization in Islets
$377,500Vanderbilt University · R21 · FY2002 · DK
Smokeless Tobacco Cessation among American Indians Using in-Person Groups
$377,500Christine Makosky Daley · University Of Kansas Medical Center · R01 · FY2016 · MD
Molecular Determinants of Vascularization in Islets
$377,500Vanderbilt University · R21 · FY2003 · DK
Smokeless Tobacco Cessation among American Indians Using in-Person Groups
$377,500Christine Makosky Daley · University Of Kansas Medical Center · R01 · FY2014 · MD
Smokeless Tobacco Cessation among American Indians Using in-Person Groups
$377,500Christine Makosky Daley · University Of Kansas Medical Center · R01 · FY2015 · MD
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
$377,438Marka Crittenden · Providence Portland Medical Center · R01 · FY2018 · CA
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
$377,438Marka Crittenden · Providence Portland Medical Center · R01 · FY2016 · CA
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
$377,438Marka Crittenden · Providence Portland Medical Center · R01 · FY2020 · CA
Rewiring the myeloid cell response to adjuvants to improve tumor control
$377,438Michael James Gough · Providence Portland Medical Center · R01 · FY2021 · CA
Rewiring the myeloid cell response to adjuvants to improve tumor control
$377,438Michael James Gough · Providence Portland Medical Center · R01 · FY2020 · CA
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
$377,438Marka Crittenden · Providence Portland Medical Center · R01 · FY2017 · CA
Utilizing islet autoantibody signatures for precision medicine in type 2 diabetes
$377,436Nisa M Maruthur · Johns Hopkins University · R01 · FY2024 · DK
Project 1: Employing CD11b-Agonists to Render PDAC Responsive to Immunotherapy
$377,428David G Denardo · Washington University · P50 · FY2025 · CA
Genetic progression of pancreatic mucinous cystic neoplasms to invasive carcinoma
$377,251Sunil R Hingorani · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA
Mechanistic Dissection of the Falconi Anemia Pathway of DNA Damage Response and Repair
$377,018Patrick Sung · University Of Texas Hlth Science Center · R01 · FY2020 · CA
Mechanistic Dissection of the Falconi Anemia Pathway of DNA Damage Response and Repair
$377,018Patrick Sung · University Of Texas Hlth Science Center · R01 · FY2021 · CA
Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer
$376,909Peter A Cohen · Mayo Clinic Rochester · P50 · FY2016 · CA
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
$376,878Tracy L McGaha · University Health Network · R01 · FY2021 · CA
Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells
$376,821Yingxiao Wang · University Of California, San Diego · R33 · FY2017 · CA
Transcriptional Regulators of Exocrine Pancreatic Development
$376,800Raymond J. Macdonald · Ut Southwestern Medical Center · R01 · FY2009 · DK
Tumor-intrinsic and paracrine roles of endoglin in pancreatic cancer
$376,732Nam Y Lee · University Of Arizona · R01 · FY2023 · CA
Clinical study of GMCI in Pancreatic Cancer
$376,666Estuardo Aguilar-Cordova · Advantagene, Inc · R43 · FY2007 · CA
Tansmission Electron Microscope for Analytical Micoscopy
$376,635Gordon Livingston Todd · University Of Nebraska Medical Center · S10 · FY2009 · RR
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN)
$376,614Ralph Weissleder · Massachusetts General Hospital · R01 · FY2022 · CA
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN)
$376,614Ralph Weissleder · Massachusetts General Hospital · R01 · FY2023 · CA